Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

PerkinElmer launches cloud-based research suite for pharmaceutical customers

By Sean Whooley | October 25, 2021

PerkinElmerPerkinElmer (NYSE:PKI) announced today that it launched the Signals Research suite for pharmaceutical and industrial customers.

Waltham, Massachusetts–based PerkinElmer’s full cloud-based Signals Research suite, deployed on Amazon Web Services (AWS) offers a secure informatics platform with integrated, end-to-end scientific data and workflow management for pharmaceutical and industrial customers.

PerkinElmer designed the platform to help drive more informed and accelerated decision-making around drug, compound and formulation candidates through PerkinElmer’s informatics technologies, according to a news release. As a result, multi-discipline R&D teams can unify critical experiment and testing data, better configure and control workflows and more effectively and efficiently manage critical scientific results, the company said.

The platform combines PerkinElmer Informatics’ Signals Notebook electronic lab notebook with the Signals VitroVivo data processing platform. It also loops in the Signals Inventa platform for data management, integration and analytics. PerkinElmer said it designed the suite to reduce experiment cycles and increase reproducibility.

“Today’s pharmaceutical and industrial companies are moving towards digital transformation and away from managing scientific data in silos,” PerkinElmer Informatics VP & GM Kevin Willoe said in the release. “They want to focus on doing better science, reduce their dependence on managing IT systems and interact with their data globally and from end-to-end.”

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Moving toward the autonomous lab and what’s possible today
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE